Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Y mAbs Therapeutics Inc (YMAB)
Y mAbs Therapeutics Inc (YMAB) Financials

YMAB Y mAbs Therapeutics Inc

8.00

-0.15 (-1.84%)

27 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-197.636	-35.033	-35.463	-44.002	-68.503	-32.059	-53.979	-15.912
Return on Equity (%)	-282.846	-40.676	-38.867	-47.744	-78.321	-38.662	-66.09	-20.387
Return on Invested Capital (%)	-282.547	-41.19	-38.995	-48.988	-79.67	-82.507	-67.481	-26.958
Operating Margin (%)	N/A	N/A	N/A	N/A	-575.118	-158.395	-145.328	-24.601
Net Profit Margin (%)	N/A	N/A	N/A	N/A	-575.118	-158.395	-146.488	-25.262
Book Value Per Share	0.729	3.071	4.11	5.007	2.601	4.084	2.433	2.255
Earnings Per Share	-1.03	-0.716	-1.266	-2.04	-2.933	-1.265	-2.189	-0.491
Cash Per Share	1.019	3.383	4.324	5.214	2.817	4.155	2.422	1.803
Working Capital Per Share	0.863	3.119	4.165	4.993	2.527	3.991	2.339	2.086
Operating Profit Per Share	N/A	N/A	N/A	N/A	0.51	0.764	1.343	1.701
EBIT Per Share	-1.03	-0.716	-1.266	-2.04	-2.933	-1.265	-2.189	-0.478
EBITDA Per Share	-1.03	-0.716	-1.266	-2.04	-2.933	-1.265	-2.189	-0.478
Free Cash Flow Per Share	-1.03	-0.716	-1.26	-1.994	-2.938	-1.261	-2.209	-0.508

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	16.55M	26.75M	34.19M	39.73M	40.69M	43.7M	43.67M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	43.67M	N/A	43.62M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-31.554	N/A	N/A	N/A	-32.457	N/A	N/A
Net Profit Margin (%)	N/A	-31.554	N/A	N/A	N/A	-33.26	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	365.03M
Price to Earnings Ratio	-16.72
Price to Sales Ratio	4.22
Price to Cash Ratio	4.56
Price to Book Ratio	3.55
Dividend Yield	-

Share Statistics

Shares Outstanding	44.79M
Average Volume (1 week)	464.32k
Average Volume (1 Month)	312.65k
52 Week Change	15.94%
52 Week High	20.90
52 Week Low	6.48

More Ratios Coming Soon!

Y mAbs Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions